We are live on ! Find out more
VA

Vident Advisory Portfolio holdings

AUM $11.7B
1-Year Est. Return 37.32%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+37.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.62B
AUM Growth
-$1.18B
Cap. Flow
-$1.18B
Cap. Flow %
-32.7%
Top 10 Hldgs %
16.49%
Holding
1,533
New
211
Increased
794
Reduced
387
Closed
126

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$52.4M
2
JNJ icon
Johnson & Johnson
JNJ
+$39.1M
3
TMUS icon
T-Mobile US
TMUS
+$37.2M
4
ABBV icon
AbbVie
ABBV
+$35.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$34.6M

Sector Composition

Rank Sector Weight
1 Technology 29.28%
2 Financials 10.77%
3 Consumer Discretionary 8.99%
4 Industrials 8.73%
5 Healthcare 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEAM icon
951
Atlassian
TEAM
$22B
$450K 0.01%
2,544
+902
+55% +$161K
TTEK icon
952
Tetra Tech
TTEK
$8.23B
$450K 0.01%
+11,000
New +$448K
IEUR icon
953
iShares Core MSCI Europe ETF
IEUR
$8.66B
$449K 0.01%
7,889
+2,035
+35% +$118K
WOR icon
954
Worthington Enterprises
WOR
$2.76B
$449K 0.01%
9,492
+4,156
+78% +$235K
MRO
955
DELISTED
Marathon Oil Corporation
MRO
$448K 0.01%
15,627
-18,550
-54% -$514K
AEIS icon
956
Advanced Energy
AEIS
$12.2B
$447K 0.01%
4,108
+509
+14% +$52.1K
RGR icon
957
Sturm, Ruger & Co
RGR
$610M
$446K 0.01%
10,712
+4,353
+68% +$193K
ACWX icon
958
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
$445K 0.01%
8,384
+1
+0% +$53
IVW icon
959
iShares S&P 500 Growth ETF
IVW
$72.5B
$445K 0.01%
4,805
+291
+6% +$25.1K
AI icon
960
C3.ai
AI
$1.27B
$444K 0.01%
+15,337
New +$394K
CLW icon
961
Clearwater Paper
CLW
$271M
$444K 0.01%
+9,157
New +$431K
ACGL icon
962
Arch Capital
ACGL
$36.1B
$442K 0.01%
4,385
+1,190
+37% +$116K
RES icon
963
RPC Inc
RES
$1.24B
$440K 0.01%
+70,395
New +$492K
ON icon
964
ON Semiconductor
ON
$33.8B
$440K 0.01%
6,415
-207,682
-97% -$14.6M
SXC icon
965
SunCoke Energy
SXC
$757M
$439K 0.01%
44,817
+20,194
+82% +$209K
NTLA icon
966
Intellia Therapeutics
NTLA
$1.5B
$439K 0.01%
19,621
+2,133
+12% +$50.8K
SPTN
967
DELISTED
SpartanNash
SPTN
$439K 0.01%
23,401
+2,665
+13% +$52K
ETR icon
968
Entergy
ETR
$54.1B
$438K 0.01%
8,180
+1,872
+30% +$101K
BEAM icon
969
Beam Therapeutics
BEAM
$2.58B
$432K 0.01%
18,453
-947
-5% -$23.3K
SIRI icon
970
SiriusXM
SIRI
$10B
$432K 0.01%
15,271
+1,615
+12% +$48.2K
RYAAY icon
971
Ryanair
RYAAY
$29.5B
$431K 0.01%
9,258
+155
+2% +$8.06K
WAB icon
972
Wabtec
WAB
$51.1B
$431K 0.01%
2,728
-99,041
-97% -$15.8M
AON icon
973
Aon
AON
$77.3B
$430K 0.01%
1,465
-65,155
-98% -$19.3M
SITE icon
974
SiteOne Landscape Supply
SITE
$4.43B
$429K 0.01%
+3,537
New +$535K
NTCT icon
975
NETSCOUT
NTCT
$2.86B
$429K 0.01%
23,458
+10,481
+81% +$207K

Similar funds

Vident Advisory's Q2 2024 Portfolio in Review

As of Q2 2024, Vident Advisory held 1,533 positions worth $3.62B, down 25% from $4.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Vident Advisory withdrew a net $1.18B in Q2 2024, closing 126 positions and reducing 387 holdings. Its most notable exit was Enterprise Products Partners, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Vident Advisory opened a new position in Vanguard Intermediate-Term Treasury ETF worth $19M.

  • Vident Advisory's largest Q2 2024 buy was Vanguard Intermediate-Term Treasury ETF: 326,646 shares worth $19M.
  • Vident Advisory added most to Tesla in Q2 2024, an estimated $29.1M increase.
  • Vident Advisory's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $52.4M.
  • Vident Advisory fully exited Enterprise Products Partners in Q2 2024, selling an estimated $20M.
  • Vident Advisory's ten largest holdings make up 16% of its $3.62B portfolio in Q2 2024.
  • Vident Advisory opened 211 new positions and closed 126 in Q2 2024.
  • Vident Advisory's portfolio value fell 25% quarter-over-quarter to $3.62B.

Based on Vident Advisory's 13F filing for Q2 2024, filed 14 Aug 2024.